Key Highlights
- REMspace secures $1M seed round from European lucid dreaming practitioners and enthusiasts.
- Funds to develop software, hardware, and dietary supplements for lucid dreaming.
- New hires include 10 engineers to enhance research and commercial projects.
- Lucid dreaming aids in fighting depression, improving mood, and promoting better sleep quality.
Source: Business Wire
Notable Quote
- “I’ve been researching the practice of lucid dreaming for several years, but humanity is still at the beginning of understanding the extraordinary benefits the practice can offer. We know that lucid dreams are a gateway to new experiences; they can help fight depression, eliminate fears, improve the practitioner’s mood and quality of life and promote sleep quality.” — Michael Raduga, CEO at REMspace
SoHC's Take
The recent $1M seed round secured by REMspace signifies a pivotal advancement in the field of lucid dreaming technologies. As a neurotechnology company, REMspace is poised to revolutionize how individuals experience and benefit from lucid dreaming. By developing innovative software, hardware, and dietary supplements, REMspace aims to make lucid dreaming more accessible and impactful for a broader audience. This not only has the potential to improve sleep quality and overall well-being but also opens up new avenues in the burgeoning “sleep economy.” The hiring of 10 new engineers underscores REMspace’s commitment to research and development, setting the stage for significant breakthroughs in this intriguing field.
